SCHEMBL6940873

SCHEMBL6940873

O=c1[nH]c2cc(Cl)c(S(=O)(=O)Nc3ccccc3)cc2cc1P(=O)(O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.45
MAPT P10636 2/20 0.45
EGLN1 Q9GZT9 1/20 0.42
BRD4 O60885 1/20 0.42
PGR P06401 1/20 0.41
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIK1 P39086 1/20 0.40
GRIA1 P42261 1/20 0.40
GRIA2 P42262 1/20 0.40
GRIA3 P42263 1/20 0.40
GRIA4 P48058 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIK2 Q13002 1/20 0.40
GRIK3 Q13003 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIK4 Q16099 1/20 0.40
GRIK5 Q16478 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650908 0.85 GRIN2D (0.45) GRIN2DGRIN3BGRIK1GRIA1GRIA2
SCHEMBL7648730 0.83 GRIN2D (0.35) MAPTGRIN2DGRIN3BGRIK1GRIA1
SCHEMBL7646348 0.83 PGR (0.39) WDR5MAPTEGLN1BRD4PGR
SCHEMBL6940270 0.83 KAT6A (0.44) GRIN2DGRIN3BGRIK1GRIA1GRIA2
SCHEMBL7646351 0.83 WDR5 (0.39) WDR5MAPTEGLN1BRD4PGR
SCHEMBL6939746 0.82 GRIN2D (0.37) MAPTGRIN2DGRIN3BGRIK1GRIA1
SCHEMBL7650675 0.82 ALDH1A1 (0.42) POLB
SCHEMBL7652655 0.80 GSTO1 (0.37) PGRGRIN2DGRIN3BGRIK1GRIA1
SCHEMBL7652701 0.80 KDM4E (0.37) MAPTGRIN2DGRIN3BGRIK1GRIA1
SCHEMBL7648786 0.80 GRIN1 (0.35) MAPTGRIN2DGRIN3BGRIK1GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125942-B1 Derivatives of 6-amino or 6-hydrazinosulfonyl-3-quinolyl phosphonic acids, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-04-09 EP claimed
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US claimed
CN-1320601-A 6-amino or 6-hydrazino-sulfonyl-3-quinolyl phosphonic acid compound, preparing process thereof and pharmaceutical composition contg. same ADIR (FR) 2001-11-07 CN claimed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US claimed
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
CN-1320601-A 6-amino or 6-hydrazino-sulfonyl-3-quinolyl phosphonic acid compound, preparing process thereof and pharmaceutical composition contg. same ADIR (FR) 2001-11-07 CN disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 WDR5 3966/4885MAPT 4631/4885EGLN1 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.